Navigation Links
The right drug at the right time

Rice scientists replace pricey solvents with cheap processing fluidsIn an important advance toward the large-scale manufacture of fluorescent quantum dots, scientists at Rice University have developed a new method of replacing the pricey solvents used in quantum dot synthesis with cheaper oils that are commonplace at industrial chemical plants.

Rice's study, which was conducted under the auspices of the Center for Biological and Environmental Nanotechnology (CBEN), is published online and slated to appear in the October issue of the journal Nanotechnology.

"CBEN started to undertake some exploratory work more than a year ago on the scale-up issues of quantum dot manufacture, but the solvents turned out to be so expensive that we just couldn't afford to run more than a few large-reactor experiments," said the study's lead author, Michael Wong, assistant professor of chemical and biomolecular engineering and of chemistry. "That was a great reality check, and it made us look at the problem of solvent cost sooner rather than later."

Quantum dots typically cost more than $2,000 per gram from commercial sources, and pricey solvents like octadecene, or ODE - the least expensive solvent used in quantum dot preparation today - account for about 90 percent costs of raw materials.

Heat-transfer fluids - stable, heat-resistant oils that are used to move heat between processing units at chemical plants - can cost up to seven times less than ODE. Replacing ODE with the heat-transfer fluid Dowtherm A, for example, reduces the overall materials cost of making quantum dots by about 80 percent.

Quantum dots are tiny crystals of semiconducting materials - cadmium selenide or CdSe is the most popular flavor - that measure just a few nanometers in diameter. Most of the commercial possibilities discussed for quantum dots - bioimaging, color displays, lasers, etc. - relate to their size-controlled fluorescence. For example, CdSe quantum dots have the ability to absorb high-energy photons of ultraviolet light and re-emit them as photons of visible light. They glow different colors, depending on the size, shifting from the red to the blue end of the spectrum as the crystals get smaller.

The reproducible synthesis of high-quality quantum dots became a reality in the early 1990s when researchers at MIT pioneered a new method of producing quantum dots with uniform sizes and well-defined optical signatures. The basic recipe for making quantum dots hasn't changed much since it was first developed. A solvent is heated to almost 500 degrees Fahrenheit, and solutions containing cadmium and selenium compounds are injected. They chemically decompose and recombine as pure CdSe nanoparticles. Once these nanocrystals form, scientists can adjust their optical properties by growing them to precisely the size they want by adjusting the cooking time.

The solvent originally used for this process was trioctylphosphine oxide, or TOPO, which costs more than $150 per liter. Later, other scientists introduced a new recipe by replacing TOPO with a mixture of ODE and oleic acid.

Wong said the CBEN research team, which included CBEN Director Vicki Colvin, professor of chemistry, and Nikos Mantzaris, assistant professor of chemical and biomolecular engineering and of bioengineering, had some initial doubts about whether heat-transfer fluids could be substituted for ODE.

"They were cheap and they didn't break down at high temperatures, but no one uses these compounds for chemical reactions," said Wong. In addition to finding that other quantum dot nanostructures could be made in heat- transfer fluids, the team concluded that any solvent could be used to replace ODE. Thanks to a mathematical modeling approach developed by Mantzaris, the team now has a method for predicting the particle size and growth behavior of quantum dots based on only three physical properties of a given solvent: viscosity, surface free energy and solubility of bulk cadmium selenide powder.


'"/>

Source:New Scientist


Related biology news :

1. Habitat use by North Pacific right whales, Eubalaena japonica, in the Bering Sea and Gulf of Alaska
2. Scientists discover that three overlapping signals in embryo help get the backbone right
3. FSU scientist warns North Atlantic right whale facing extinction
4. Purdues gold nanorods brighten future for medical imaging
5. Einstein scientists discover how protein crucial for motion is synthesised at the right place in the cell
6. Wright bros. upstaged! Dinos invented biplanes
7. How does the brain know what the right hand is doing?
8. Forsyth scientists gain greater understanding of how embryos differentiate left from right
9. Brighter future for giant panda?
10. Finding the right mix: A biomaterial blend library
11. Striking the right balance between excitation and inhibition
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is pleased ... received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of ... Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform ...
Breaking Biology Technology: